Company:  PROCESSA PHARMACEUTICALS, ... (PCSA)
Form Type:  8-K
Filing Date:  6/10/2021 
CIK:  0001533743 
Address:  7380 COCA COLA DRIVE
SUITE 106
 
City, State, Zip:  HANOVER, Maryland 21076 
Telephone:  443-776-3133 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$5.98  
Change: 
-0.34 (-5.38%)  
Trade Time: 
Jul 30  
Market Cap: 
$93.09M
Trade PCSA now with 

© 2021  
Description of Business
Our mission is to develop drug products that improve the survival and/or quality of life for patients with high unmet medical need conditions. We are a development company, not a discovery company, that seeks to identify and develop drugs for patients who need better treatment options than presently exist for their medical condition. In order to increase the probability of development success, our pipeline only includes drugs which have previously demonstrated some efficacy in the targeted population or a drug with very similar pharmacological properties has been shown to be effective in the population. We are a clinical-stage biopharmaceutical company focused on the development of drug products that are intended to provide treatment for patients who have a high unmet medical need condition that effects survival or the patient's quality of life and have few or no treatment options. We currently have three drugs in various stages of clinical development.
Register and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.07. Submission of Matters to a Vote of Security Holders.
    SIGNATURES